Abstract
In this 60-minute webinar, Pr. Oliver Frey will notably:
- Introduce plasma cell neoplasms and other diseases with paraprotein
- Explain the role of free light chains (FLC) in diagnosis and follow-up of plasma cell neoplasms
- Give an overview on available free light chain assays: technical and methodological aspects
- Outline what is important in selecting a FLC assay: reference interval, CKD, clinical performance
- Detail lessons learned when switching FLC assays
Speaker’s biography
Pr. Oliver Frey is a specialist in laboratory medicine.
He is medical director of the IMD Berlin MVZ and specializes in immunological diagnostics and the diagnosis of hematological neoplasia.
Pr. Frey is also involved in accreditation procedures as an expert assessor in the field of immunology and is committed to quality-assured, precise and patient-centered medical diagnostics.
Speaker
Free Light Chains* (FLC)
The next generation Free Light Chain Assay.
* Under Product Registration approval
This section contains information intended for wide distribution and may therefore contain product details or information that is not available or valid in your country.
Please contact your local Sebia representative. Information intended for healthcare professionals.
Carefully read the instructions in the reagent package inserts and instrument manuals.